Transcriptomics

Dataset Information

0

Ketone and glycolytic metabolism are key modulators of inflammation during neonatal sepsis


ABSTRACT: Neonatal sepsis is a life-threatening condition in preterm infants, primarily due to a dysregulated immunometabolic response to infection. Sepsis and infection mortality are associated with excessive glycolysis-induced inflammation, impaired mitochondrial oxidative phosphorylation (OXPHOS) and loss of disease tolerance. Reduced glucose intake can reverse these dysregulations, but it is unclear how the mechanistic control of glycolysis-OXPHOS balance drives defense strategies and infection outcomes. Here, in a preterm piglet model of neonatal sepsis, glycolysis inhibition with 2-deoxyglucose (2-DG) completely prevents acute infection mortality, reduces systemic inflammation and markers of liver injury, accompanied by enhanced mitochondrial metabolism and disease tolerance. Strikingly, this protection by 2-DG is conferred despite elevated blood glucose levels and higher bacterial burdens than the infected controls. Alternatively, partial replacement of glucose intake with the ketone beta-hydroxybutyrate (BHB) abolishes sepsis-related mortality via improving disease tolerance and clinical parameters.

ORGANISM(S): Sus scrofa

PROVIDER: GSE319552 | GEO | 2026/02/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-06-29 | GSE201552 | GEO
2024-06-30 | GSE263512 | GEO
2023-11-20 | GSE247865 | GEO
2022-06-29 | GSE201550 | GEO
2016-05-29 | E-MTAB-4785 | biostudies-arrayexpress
2023-11-23 | GSE236099 | GEO
2020-05-26 | PXD016013 | Pride
2020-02-03 | GSE113572 | GEO
2025-07-28 | GSE303231 | GEO
2016-03-07 | GSE74182 | GEO